Dear Editor, Black individuals have a higher incidence of multiple myeloma (MM) and worse survival than White patients [1]. Growing evidence suggests that these survival differences are due to inequities in timely diagnosis and effective treatment utilization [2,3,4], given that Black patients generally exhibit equal or better survival than White patients after adjustment for key treatment-access barriers [2, 5].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jason
Contact Jason, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack